Autophagy is the basic catabolic progress involved in cell degradation of unnecessary or dysfunctional cellular components. It has been proven that autophagy could be utilized for cell survival under stresses. Hypoxic-preconditioning (HPC) could reduce apoptosis induced by ischemia and hypoxia/serum deprivation (H/SD) in bone marrow-derived mesenchymal stem cells (BMSCs). Previous studies have shown that both leptin signaling and autophagy activation were involved in the protection against apoptosis induced by various stress, including ischemia-reperfusion. However, it has never been fully understood how leptin was involved in the protective effects conferred by autophagy. In the present study, we demonstrated that HPC can induce autophagy in BMSCs by increased LC3-II/LC3-I ratio and autophagosome formation. Interestingly, similar effects were also observed when BMSCs were pretreated with rapamycin. The beneficial effects offered by HPC were absent when BMSCs were incubated with autophagy inhibitor, 3-methyladenine (3-MA). In addition, down-regulated leptin expression by leptin-shRNA also attenuated HPC-induced autophagy in BMSCs, which in turn was associated with increased apoptosis after exposed to sustained H/SD. Furthermore, increased AMP-activated protein kinase phosphorylation and decreased mammalian target of rapamycin phosphorylation that were observed in HPC-treated BMSCs can also be attenuated by down-regulation of leptin expression. Our data suggests that leptin has impact on HPC-induced autophagy in BMSCs which confers protection against apoptosis under H/SD, possibly through modulating both AMPK and mTOR pathway.
Although severe hypoxia can lead to cell death for certain cell types such as endothelial cells, repeated episodes of short periods' exposure to hypoxia (hypoxic-preconditioning) have shown conferring cytoprotective benefits. Research done in our laboratory and others has revealed that hypoxic-preconditioning protects bone marrow-derived mesenchymal stem cells (MSCs) from apoptosis and enhances cell survival after implantation [1, 2] . However, the mechanisms underlying the beneficial effects of hypoxia preconditioned MSCs remain unclear.
Autophagy is the cellular process responsible for the degradation and removal of damaged organelles and protein aggregates [3] . Autophagy is critical to cell survival. The interruption of autophagy may initiate severe energy metabolism disorder and cell death [4] . Many scientists have reported that activation of autophagy protects MSCs from apoptosis [5] . Recent cancer research demonstrates that hypoxia activates autophagy and promotes tumor cell survival [6] . We hypothesized that hypoxic-preconditioning induces autophagy of bone marrow-derived MSCs (BMSCs), and it activates autophagy to protect MSCs from hypoxia and serum deprivation.
Recently, research data from our lab and others suggested that hypoxia induces leptin expression [7, 8] . Leptin, the 16-kD nonglycosylated polypeptide product of the ob gene, is synthesized mainly by white adipose [9] . The best-known function of leptin is to regulate appetite. Leptin acts on cells in hypothalamus to reduce the production of orexigenic neuropeptides and reciprocally enhance the secretion of anorectic peptides, thus controlling food intake [10] . Beyond its function as a satiety factor, leptin has a wide range of biological functions, including reproduction, immunity, angiogenesis, and anti-apoptotic effects. Recent reports of in vivo administration of leptin activating AMP-activated protein kinase (AMPK) phosphorylation in peripheral tissues suggests that it may influence autophagy [11, 12] . In vitro studies demonstrated that leptin stimulated autophagy in cultured human or mouse cell lines, a phenomenon that was linked to the activation of AMPK as well as the inhibition of mammalian target of rapamycin (mTOR) [13] .
The objective of this study was to find out whether leptin has any contribution to increased autophagy induced by hypoxic-preconditioning in BMSCs. Increased autophagy protects stem cells from apoptosis under sustained hypoxia/serum deprivation (H/SD).
Materials and methods

Cell culture
Bone marrow was harvested from the tibia and femur of C57/BL6 mouse (20-25 g, male) and seeded into cell culture flasks with DMEM (Gibco, USA) containing 10% FBS (Gibco) and 1% penicillin-streptomycin (Gibco) at 37°C in a humidified atmosphere containing 5% CO 2 . After 24 h, non-adherent cells were discarded, adherent cells were washed three times with phosphate buffered saline (PBS). Fresh complete medium was added. When the cells reached 80% confluence, they were detached using 0.25% trypsin-EDTA (Gibco) and subcultured at the ratio of 1 : 2. All cells used in the experiment were passage 3.
Hypoxic preconditioning and H/SD
For hypoxia treatment, cells were plated at 5×10 4 cells per well in 6-well plates in complete culture medium and incubated under hypoxia condition (0.5% O 2 , 5% CO 2 ) using ProOX Model C21 system (BioSpherix, USA) for 6, 12 and 24 h, respectively. After hypoxic preconditioning, the MSCs were washed with PBS, and incubated under hypoxia condition (0.5% O 2 , 5% CO 2 ) with serum-free medium for 48 h. 3-methyladenine (3-MA, at 5 mmol L 1 from SigmaAldrich, USA) and rapamycin (25 mmol L 1 from Cell Signal Technology, USA) were added to inhibit or induce autophagy, respectively, to further investigate the role that autophagy activation plays in protection apoptosis in MSCs.
Infecting BMSCs with leptin targeting shRNA
For the leptin-knockdown assay, low passage number mouse BMSCs were transduced with a lentiviral vector carrying mouse leptin shRNA (LV-LEP-RNAi, purchased from Shanghai SBO Medical Biotechnology Co. Ltd.
(Shanghai, China)). 5×10 5 BMSCs were seeded and incubated at 37°C, 5% CO 2 overnight. At ~70% confluency, 0.5 mL of filtered lentiviral supernatant (5×10 7 titer units) containing 8 mg mL 1 Polybrene (Sigma, USA) was added (MOI=100). After 24 h, the virus-containing medium was replaced with fresh medium. To select infected cells, puromycin (2.5 µg mL 1 ) was added and incubated for 24 h.
According to Leptin mRNA sequence (NM_008493), Leptin targets shRNA constructs. The target oligonucleotides were designed at the position in gene sequence from 897 gene site. Two cDNA template chains were designed and Age I, EcoR I enzyme cleavage sites were introduced at the terminals. The sequences of shRNA that directed against the mice Leptin were as follows: sense, 5′-CCGGTCTGCAG-GACATTCTTCAATTCAAGAGATTGAAGAATGTCCT GCAGATTTTTTG-3′; antisense, 5′-AATTCAAAAA-ATCTGCAGGACATTCTTCAATCTCTTGAATTGAAG AATGTCCTGCAGA-3′. The sequences of scrambled shRNA were sense, 5′-CCGGTTCTCCGAACGTGTCA-CGTTTCAAGAGAACGTGACACGTTCGGAGAATTTT TG-3′; antisense, 5′-AATTCAAAAATTCTCCGAACGT-GTCACGTTCTCTTGAAACGTGACACGTTCGGAG-AA-3′. The double-stranded oligonucleotides were cloned into the linear vector containing enhanced green fluorescent protein (EGFP) gene. 
Immunofluorescence staining
Western blotting
Equal amounts of protein (40 µg/lane) were separated by electrophoresis for Western blotting analysis. The proteins were transferred for 2.5 h at 250 mA onto PVDF membranes (Bio-Rad, UK), and the membranes were blocked for 1 h at room temperature in 5% skim milk. The membranes were then incubated overnight at 4°C with primary antibodies. The following primary antibodies were used: phosphorylated (Thr172) and total AMPK, phosphorylated (serine 2448) and total mTOR, beclin1, light chain 3 (LC3) of microtuble-associated protein 1, cleaved caspase-3, and β-actin from Cell Signal Technology. The membranes were washed and incubated for 1 h at room temperature in blocking solution containing peroxidase-conjugated secondary antibodies. Then the membranes were washed again and processed for analysis by using a Chemiluminescence Detection Kit (Millipore, USA) as instructed by the manufacturer.
Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay
TUNEL assay was performed using In Situ Cell Death Detection Kit, TMR red (Roche Applied Science, USA) according to manufacturer's procedure. Briefly, treated cells grown on 24-well plates with cover slips in each well were fixed in 4% paraformaldehyde, then permeabilized using 0.1% TritonX-100 in 0.2% sodium citrate and incubated in TUNEL reaction mixture for 1 h at 37°C. Cover slips were mounted on glass slides with Vectashield mounting medium with DAPI (1.5 µg mL 1 , Vector Laboratories, Inc., USA) and analyzed by fluorescence microscopy to observe DNA fragmentation. Quantification of TUNEL positive cells was performed using Image Pro.
Statistical analysis
Data were analyzed using SPSS 15.0 software. All values were presented as mean±SD. Differences among groups were tested by one-way analysis of variance. Two-sided P-values were used and P<0.05 was considered statistically significant.
Results
Autophagy was induced in BMSCs after hypoxic preconditioning
To investigate hypoxic preconditioning-induced autophagy in BMSCs, we detected the levels of the type II LC3 (LC3-II), a biochemical marker of autophagy, by Western blotting. Under normal condition, LC3 protein exists in the cytosol as type I (LC3-I). When autophagy is activated, LC3-I can be recruited by autophagosome membrane and converted to LC3-II [14] . As shown in Figure 1A , compared with the control group (normoxic-treated), the ratio of LC3-II/LC3-I was significantly increased after HPC (6-12 h) and autophagy promoter rapamycin (25 nmol L 1 ) treatment for 6 h, although the expression of autophagic marker beclin1 had no significant difference among groups. Moreover, treatment with autophagic inhibitor 3-MA (5 mmol L 1 )
attenuated the HPC-induced autophagy. We also performed an immunofluorescence assay to evaluate LC3, which is an early marker for autophagosome. As shown in Figure 1C , the green dots represent LC3 that was detected in the cytoplasm of BMSCs. Compared to the control group, the expression of LC3 increased after HPC (612 h) and being treated with rapamycin (25 nmol L 1 ). This suggested that HPC elicited autophagosomes. However, HPC-elicited autophagosomes decreased after 3-MA treatment.
HPC-induced autophagy protected BMSCs from apoptosis under H/SD condition
To investigate the association of autophagy and apoptosis, we treated BMSCs with autophagy promoter rapamycin or hypoxic preconditioned with or without autophagy inhibitor 3-MA, and then exposed them to H/SD for 24 h. As shown above, the autophagic activity in BMSCs was induced significantly in the groups that had HPC (612 h) and rapamycin treatment compared to the control group. This was showed by higher LC3-II/LC3-I ratio ( Figure 1A ) and more autophagosome formation ( Figure 1C ). 3-MA suppressed the autophagic activity induced by HPC in BMSCs. Additionally, apoptosis analysis performed via terminal deoxynucleotidyl TUNEL staining indicated that enhancing BMSCs autophagy by rapamycin and HPC significantly attenuated the apoptosis ratio of BMSCs under H/SD (Figure 2B ) when compared to the control group. 3-MA-treated BMSCs showed a higher rate of apoptosis ( Figure 2B ). We also found the expression of cleaved caspase-3 was enhanced by 3-MA while reduced by rapamycin and HPC significantly (Figure 2A ). These results suggested that HPC-induced autophagy played a protective role in BMSCs apoptosis under H/SD.
Leptin-knockdown attenuated HPC induced autophagy of BMSCs
It has been reported that HPC increased the expression of leptin which could induce autophagy in several cell lines under certain conditions. To test whether leptin was able to modulate autophagy in HPC-BMSCs, we used shRNA to down-regulate leptin expression in BMSCs, then exposed BMSCs to HPC for 12 h. As shown in Figure 3A , LC3-II, identified by Western blot, elevated in HPC-WT (wild type) and NC (negative control) groups when compared to the control group. However, leptin-knockdown led to a decrease of the LC3-II in HPC BMSCs, whereas this negative effect was absent when rapamycin was added ( Figure 3A ). In addition, we found that the number of autophagosomes observed in HPC-Leptin-knockdown-BMSCs was significantly decreased compared with HPC-WT and NC groups. This decrease could be reversed by rapamycin treatment ( Figures 3C and 4) . These results suggested that leptin is a key factor for the enhanced autophagic activity in MSCs exposed to HPC.
Leptin knockdown attenuated the protective effect of HPC-induced autophagy against apoptosis in H/SDtreated BMSCs
We have confirmed that leptin plays an important role in HPC-induced autophagy in BMSCs. To further test the function of leptin in the protective effects of autophagy, leptin-knockdown BMSCs were hypoxic preconditioned for 12 h with or without rapamycin, then exposed to H/SD for 24 h. As shown in Figure 5B , the ratio of apoptosis identified by TUNEL assay demonstrated that HPC protected WT and NC BMSCs from apoptosis induced by H/SD. However, while leptin knockdown attenuated the anti-apoptotic capacity of HPC, rapamycin treatment restored the protective effect ( Figure 5B) . From Western blot analysis, we found that leptin knockdown also led to the increase in cleaved caspase-3 at 24 h of H/SD in HPC BMSCs compared to that of the groups that had HPC-WT, HPC-NC, and rapamycin treatment ( Figure 5A ). These results indicated that leptin might play an important role in the protective effect of HPC-induced autophagy.
HPC-induced autophagy regulated by leptin was associated with AMPK/mTOR pathway
Several studies have shown that AMPK/mTOR pathway plays a role in regulating autophagy. During the experiment, we also investigated whether the AMPK/mTOR pathway is associated with HPC-induced autophagy, which is regulated by leptin. The results from Western blot indicated that HPC did stimulate the activation of phosphorylation of AMPKα as well as the dephosphorylation of mTOR after 12 h. However, leptin knockdown abrogated the effects of HPC on both AMPK phosphorylation and mTOR dephosphorylation which could be reversed by autophagy promoter rapamycin ( Figure 6 ). These results suggest that AMPK/ mTOR pathway might play a role in the stimulating function of leptin on HPC induced MSC autophagy.
Discussion
Scientists have been studying stem cells as useful tools for regenerative medicine. Stem cells have the potential to protect, repair, and regenerate impaired tissues. Working with embryonic stem cells has many drawbacks, such as genetic mutations, teratomas formation, difficult ethical considerations, and possibility of immune rejection [15] . To overcome these limitations, MSCs have been studied as an alternative source for cell therapy, because they are easy to prepare, have immunologic advantages, and involve no ethical controversy [16] . However, cell transplantation application with MSCs is hampered by early cell death, partially due to oxygen or nutrient deprivation; therefore how to enhance MSCs survival has received much attention.
In our current study, the results showed that autophagy was promoted in BMSCs after hypoxic preconditioning (peaked at 12 h) and it served as a protector for BMSCs apoptosis under H/SD. Leptin may regulate HPC-induced autophagy via AMPK/mTOR pathway. To our knowledge this is the first report showing that leptin regulates HPC-induced autophagy in BMSCs, which protects BMSCs from apoptosis under H/SD.
Autophagy plays key roles in cellular physiology, such as degradation of long-lived proteins, organelle turnover, adaptation to nutrient depletion, and cellular homeostasis consistency [17, 18] . Autophagy which has contributions to cell survival or death in response to a stressor can be dramati- cally induced by multiple stresses. The relationship between autophagy and death has been characterized in many contexts and has been discussed comprehensively; however, it has not been extensively studied in BMSCs. Hypoxia and serum deprivation are both energy-limiting stresses impairing the function of mitochondria and stimulating the production of radicals. According to numerous studies, adaptive autophagy is essential for cell survival by supplying energy and eliminating radicals and damaged organelles [1921] . The protective effect of autophagy has been previously reported in models of ischemic injury in the heart, brain, and under conditions of H/SD in cell culture [2224] . Recently, Sanchez et al. [20] reported that during long period of serum deprivation, MSCs could utilize autophagy to provide needed energy and secret anti-apoptotic factors for survival. In our research we found that autophagic pathway was activated effectively by hypoxic-preconditioning as shown by increased autophagosomes, LC3-II, and decreased apoptosis ratio of BMSCs under H/SD. Moreover, suppressing autophagy by its inhibitor 3-MA resulted in increased apoptotic levels in H/SD-treated MSCs. In contrast, rapamycin, an autophagy inducer, could decrease the degree of apoptosis. These data suggested that HPC could promote autophagy in BMSCs as a pro-survival mechanism rather than a pro-death pathway in BMSCs under H/SD.
Interestingly, research data from our lab and others suggested that the expression of leptin was increased in MSCs after HPC. Leptin is a well-known molecule that promotes cell survival both in vivo and in vitro through various mechanisms [25, 26] . In addition, recent research suggested that leptin induced autophagy in cultured human or mouse cell lines [13] . In this study conducted on BMSCs, we showed that leptin knockdown reduced HPC-induced autophagy by decreasing the LC3-II and autophagosomes. Autophagy promoter rapamycin abrogated these changes observed in the HPC-leptin-knockdown BMSCs group, suggesting that leptin does regulate HPC-induced autophagy. Furthermore, HPC-induced, autophagy mediated antiapoptosis effects on BMSCs under H/SD were significantly diminished by leptin-knockdown, while rapamycin reversed this leptin-knockdown effect. This confirmed our hypothesis that HPC induces autophagy through leptin and promotes BMSCs survival during H/SD.
It is noteworthy that in our study, the level of beclin1, a well-known autophagy-related protein, was not associated with the autophagic activity. However, as previous studies reported, the expression of beclin1 is augmented significantly when autophagy is induced [22, 27] . This discrepancy may be due to the difference in cell types, stimuli, and duration of treatment applied to individual studies. Carloni et al. [28] have reported that applying hypoxia-ischemia stimulation for the same duration only induced beclin1 in neurons but not in other cells. Moreover, the treatment time associated with autophaic markers' increase also differed widely from cell to cell. Thus, in our study, the short period of HPC may be the reason of lack of beclin1 expression.
Up to now, many signaling pathways have been suggested in autophagy regulation. AMPK is thought to be an important positive regulator of autophagy via its indirect inhibition to mTOR [29] . Recent investigations suggested that leptin administration activates AMPK. Therefore, we monitored the expression and activation levels of AMPK/ mTOR pathway to further study the mechanism underlying HPC-induced autophagy. Interestingly, we found that HPC increased the AMPK activation and simultaneously reduced the mTOR activation significantly. Moreover, leptinknockdown not only counteracted the mTOR suppression and AMPK activation, but also eliminated the autophagy induced by HPC. In contrast, autophagy promoter rapamycin changed the signaling pathway of leptin-knock-down mediated by AMPK activation and mTOR, indicating that leptin and rapamycin may share the same signaling pathway in regulating autophagy in BMSCs, i.e., through mTOR inhibition. There may be many other mediators responsible for the autophagy. As other studies reported, leptin could also activate PI3K/Akt, STAT3, NF-kappaB, and ERK1/2 pathway to mediate the protection effects which are found to be able to signal autophagy as well [3032]. Thus, further study is necessary to identify other signaling pathways used by leptin to regulate HPC-induced autophagy and protect BMSCs against apoptosis.
In conclusion, the results reported here strongly suggest that HPC induced autophagy in BMSCs protects BMSCs from apoptosis under H/SD. Leptin may be an important factor in regulating HPC-induced autophagy via AMPK/ mTOR pathway. These findings provide valuable information for better understanding of autophagy-regulated mechanisms that promote BMSCs survival.
